Related Experiment Video
Updated: May 24, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neonatal growth charts
Enrico Bertino1, Paola Di Nicola, Alessia Varalda
1Cattedra di Neonatologia, Dipartimento di Scienze Pediatriche e dell'Adolescenza, Università degli Studi di Torino, Torino, Italy. enrico.bertino@unito.it
Insights
Accurate neonatal growth assessment is crucial. New Italian Neonatal Study (INeS) charts offer improved neonatal anthropometric references, addressing limitations of existing growth charts for preterm infants.
Area of Science:
- Neonatology
- Pediatric Endocrinology
- Medical Statistics
- Clinical Epidemiology
Background:
- Recognizing abnormal growth at birth and intrauterine malnutrition is vital for neonatal care and prognosis.
- Current neonatal auxological evaluation relies on anthropometric and intrauterine growth charts, but methodological issues limit comparability.
- Existing charts have limitations for monitoring the postnatal growth of preterm newborns.
Purpose of the Study:
- To produce reliable Italian neonatal anthropometric reference charts (INeS charts) meeting stringent criteria.
- To address the need for improved growth monitoring tools for preterm infants.
- To establish a comprehensive growth monitoring strategy for infants from birth to 20 years.
Main Methods:
- A multicenter survey was promoted by leading Italian medical societies.
- Development of new Italian Neonatal Study (INeS) charts for neonatal anthropometry.
- Integration of international longitudinal charts (WHO 2006, CDC 2002) and SIEDP charts for comprehensive growth monitoring.
Main Results:
- The INeS charts provide a reliable reference for neonatal anthropometry up to term.
- A proposed strategy combines INeS charts, WHO/CDC charts, and SIEDP charts for continuous growth monitoring.
- This approach aims to overcome limitations of existing charts for preterm infant growth assessment.
Conclusions:
- The INeS charts represent a significant advancement in Italian neonatal anthropometric references.
- A combined approach using INeS, WHO/CDC, and SIEDP charts offers a practical solution for monitoring infant growth in Italy.
- This strategy enhances the evaluation of postnatal growth for preterm infants from birth to 20 years.
Abstract:
The ability to recognize abnormal growth at birth and/or an intrauterine malnutrition is of great importance for neonatal care and prognosis. The current gold standard in neonatal auxological evaluation is based on information obtained from both neonatal anthropometric charts and intrauterine growth charts. Numerous charts have been proposed, but they are hardly comparable with each other, due to numerous methodological problems. The Italian Society of Neonatology, the Italian Society of Pediatric Endocrinology and Diabetology and the Italian Society of Medical Statistics and Clinical Epidemiology promoted a multicenter survey with the aim to produce an Italian neonatal anthropometric reference (Italian Neonatal Study [INeS] charts) fulfilling the set of the criteria that a reliable neonatal chart should possess. In clinical practice neonatal charts have some limitations if they are used to monitor postnatal growth of preterm newborns from birth to term. To overcome the problems related to the construction and use of a reference, an international project has recently started a study aiming to create prescriptive standard for the evaluation of postnatal growth of preterm infants (INTERGROWTH-21st). While an international longitudinal standard for evaluating preterm infant postnatal growth is lacking, in Italy the best compromise is likely to be as follows: new INeS charts up to term; International longitudinal charts WHO 2006 or CDC 2002 from term to 2 years; finally, the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP) growth charts could be suitable for monitoring the growth of these infants from 2 years up to 20 years of age.
Related Concept Videos
Oxygen Requirements and Growth Patterns
Bacterial Growth Curve
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Growth of Cartilage and Bone Tissue
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

